DeviceTalks Podcast Network

In this episode, we’ll dive deep into the Heart Failure business at Abbott. First we’ll connect with Philip Adamson, MD, chief medical officer of the group. Dr. Adamson uses an explanation of CardioMEMS to give a vivid portrait of how patients live with heart failure. Technology, he says, makes turns those patients into their own health care workers.

This podcast is sponsored by KNF.

Then, we’ll talk with Kevin Bourque, vice president of research and development, and Robert Kormos, division VP, global affairs of heart failure, about the advances of Heartmate 3. Both also detail how Abbott is working to help children suffering from the condition.

Dr. Kormos also shares the most gratifying part of his job.

The entire editorial staff joins the podcast to share their personal top stories of 2021. News includes mentions from Vicarious Surgical, ResMed, Philips, Pfizer, BioNTech, Abbott, Dexcom and Insulet.

Happy New Year!!! We'll see you in 2022.

LIKE! FOLLOW! SUBSCRIBE!

In this episode we’ll explore potentially life-saving treatments for hypertension and stroke.

First, we’ll talk with Sandra Saldana, CEO of the start-up Alva Health, which is developing a wearable system that can detect strokes. Alva Health won the 2021 Global Competition of the Medtech Innovator program.

Then we’ll explore renal denervation, the exciting but vexing method of lowering hypertension by ablating nerves in the kidney.

We’ll talk to the leaders in this space including Andy Weiss, CEO of Recor Medical, a division of Otsuka Holdings, that’s developing the Paradise Renal Denervation system.

Weiss, a medtech veteran, shares his long-term views, one why he still sees Renal Denervation as a game-changer.

Then, we’ll run an excerpt of the MedtronicTalks podcast interview with Jason Weidman, senior vice president and president of the coronary and renal denervation business at Medtronic.

Weidman details Medtronic’s latest regulatory hiccups but, like Weiss, explains why he sees renal denervation as an important new therapy that can save the lives of people struggling to control their hypertension.

You can listen to the entire interview with Weidman here. https://www.devicetalks.com/weidman-talks-us-through-the-long-road-to-get-symplicity-ready-to-help-patients-with-hypertension/.

In this episode, we learn about the data collecting during surgical robotic systems. Chief Digital Officer Brian Miller and Tony Jarc, Director, Research and Data Science , detail the importance of data being collected by Intuitive’s surgical robotic systems and how the company uses the data to help guide surgeons in the future.

In this episode, we’ll do a deep dive with Stryker Corp., which recently hosted an in-person analyst day.

In our first interview Andy Pierce, group president of MedSurg and Neurotechnology, will update us on his group’s wide-ranging portfolio, including an artificial intelligence-enabled tool to save the lives of patients at risk of dying of post-partem hemorrhaging.

Kevin Lobo, chair and CEO, visits next to update on the company’s plans to keep building on its market leader status. We’ll talk about the Wright Medical integration, what makes a good acquisition, and how the rise of surgical robotics is helping Stryker build out its MAKO product.

In between all this, co-costs Tom Salemi and Chris Newmarker review this week’s Newmarker’s Newsmakers including items from GE Healthcare, Best Buy, the FDA, DePuy Synthes and Boston Scientific.

We also talk about pie.

Just a short message from Tom and Chris, two grateful guys who don't like pumpkin sausage.

This week’s discussion begins on the stage in Las Vegas where Tom Salemi interviewed Kwame Ulmer of Ulmer Ventures and Medtech Color at Medmarc’s annual broker meeting.

This episode is sponsored by Medmarc.

The conversation hit upon five areas that have changed over the past two years due to the pandemic or critical concerns over equity and fairness.

In this podcast, Ulmer speaks to the slow progress being made in medtech in diversifying the workforce. But he also offers signs of hope and introduced Medtech Color.

Ulmer will also speak to improvements made at the FDA, where he started his medtech career. He also provides an update on a comprehensive survey of the FDA being conducted by the biomed program at UCLA.

We’ll also hear post-conference interviews with Jennifer Fried, CEO of Explorer Surgical, who will share how that company successfully pivoted during the pandemic.

Mark Leahey, CEO of MDMA, will update on the MCIT ruling that would deliver surer reimbursement for medical device companies with breakthrough products.

Finally, Jonathan Norris of Silicon Valley Bank shares surprising changes to early and late-stage financings as well as medical device exits.

Subscribe to this podcast on all major podcast applications.

In this week’s episode, we follow up on our first episode focused on Transcatheter Aortic Valve Replacement (TAVR). This time we speak with one of the market leaders, Medtronic, about their broad structural heart portfolio. Nina Goodheart, president of Structural Heart, walks us through each valve and explains why Medtronic is sponsoring a clinical trial pitting its aortic valve against a rival’s. We also hear from the new competitor on the block, Abbott, which recently earned FDA approval for its valve. Santosh Prabhu, PhD, introduces the new entry and explains why this work is so important to him personally.

In the second episode of IntuitiveTalks, two senior executives explain how the company gets surgeons and hospitals to understand the benefits of the Da Vinci system.

EVP Dr. Myriam Curet, who describes herself as a late adopter of technology, shares why she opted to join Intuitive as CMO early on after trying the Da Vinci robot.

Similarly, SVP Gillian Duncan, who heads physician training and development, says her early experience with the robotic system convince her to leave her academic career to join the robotics pioneer.

Subscribe to this podcast on all major podcast applications.

This week we’ll hear from Chris Barry, CEO of NuVasive. Barry joined NuVasive at a critical period in 2018. Now, the company is building out its portfolio of surgical tools, adding a digital surgery platform, planning its own move into robotics and finally making training much easier for its surgeons through new facilities, both real and virtual.

Danielle Kirsh, senior editor, and Jim Hammerand, deliver the highlights from this month’s Medical Design and Outsourcing Magazine, our Women in Medtech issue. Danielle reveals some disheartening news about jobs and research dollars going to women while Jim shares hopeful details from some of the profiles.

Chris Newmarker, executive editor, identifies this week’s Newmarker’s Newsmakers – Avail Medsystems, Integra Lifesciences, GE, Medtronic and NuVasive.

Subscribe to this podcast on all major podcast applications.

The surgical robots are back in this episode of the DeviceTalks Weekly Podcast. First we’ll speak with Megan Rosengarten, president of robotics at Medtronic, about what the CE Mark for the Hugo surgical robot system means for current and future applications.

Then, we speak with Ivan Tornos, COO of Zimmer Biomet, about that company’s broad technology offerings include ZBEdge, PersonaIQ Knee Implant, and other digital data collectors. Tornos says Zimmer Biomet intends to be the boldest company in the medtech industry.

Chris Newmarker is back to deliver this week’s Newmarker’s Newsmakers – Intuitive Surgical, Xenter, Moderna, Medtronic, and Johnson & Johnson.

Associate Editor Sean Whooley joins in on the fun.

Subscribe to this podcast on all major podcast applications.